Eledon Pharmaceuticals In...

NASDAQ: ELDN · Real-Time Price · USD
2.63
0.03 (1.15%)
At close: Aug 15, 2025, 3:59 PM
2.60
-0.95%
After-hours: Aug 15, 2025, 06:25 PM EDT

Eledon Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-36.18M -116.54M -87.97M -34.51M
Depreciation & Amortization
359K 374K 373K 195K
Stock-Based Compensation
13.12M 6.54M 8.15M 7.9M
Other Working Capital
959K -2.32M 287K -2.29M
Other Non-Cash Items
-33.71M 75.01M 48.65M 6.15M
Deferred Income Tax
431K n/a n/a -2.35M
Change in Working Capital
8.71M -4.92M 2.37M -152K
Operating Cash Flow
-47.27M -39.53M -28.42M -28.91M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-156.13M -78.29M n/a n/a
Sales Maturities Of Investments
85.82M 33M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-70.31M -45.29M n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
215K n/a n/a -449K
Financial Cash Flow
133.52M 33.02M n/a -449K
Net Cash Flow
15.94M -51.8M -28.42M -29.36M
Free Cash Flow
-47.27M -39.53M -28.42M -28.91M